Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Acro Biomedical (ACBM) Inventory (2017 - 2022)

Acro Biomedical (ACBM) has 6 years of Inventory data on record, last reported at $296000.0 in Q3 2022.

  • For Q3 2022, Inventory fell 33.93% year-over-year to $296000.0; the TTM value through Sep 2022 reached $296000.0, down 33.93%, while the annual FY2020 figure was $938000.0, 6.77% up from the prior year.
  • Inventory reached $296000.0 in Q3 2022 per ACBM's latest filing, roughly flat from $296000.0 in the prior quarter.
  • Across five years, Inventory topped out at $1.1 million in Q3 2018 and bottomed at $296000.0 in Q2 2022.
  • Average Inventory over 5 years is $722691.8, with a median of $878560.0 recorded in 2019.
  • Peak YoY movement for Inventory: surged 252.63% in 2019, then plummeted 66.98% in 2020.
  • A 5-year view of Inventory shows it stood at $360000.0 in 2018, then soared by 144.04% to $878560.0 in 2019, then rose by 6.77% to $938000.0 in 2020, then tumbled by 52.24% to $448000.0 in 2021, then crashed by 33.93% to $296000.0 in 2022.
  • Per Business Quant database, its latest 3 readings for Inventory were $296000.0 in Q3 2022, $296000.0 in Q2 2022, and $448000.0 in Q3 2021.